thesi updat thermo compani mission domin
tool annihil ep estim think marc may even
said could super fabul us sound pretti
bullish thu concern initi guid surprisingli
quickli fade delta easili explain lack
gatan fx headwind divestitur ap adjust
item comfort growth
rang becom standard also got core
guid proper tone sensit macro
nail balanc furthermor materi
balanc sheet capac even abil
hold rang growth slow drive upsid macro
remain strong slightli dubiou thu remain
all-weath stock view despit mix view tool
overal tweak year forecast pt bump
frankli bit surpris share arent act
favor lag modest ytd buyer
reiter overweight rate
model/pt updat forecast remain consist
boost core lower tax rate partial off-set
ap divestitur fx forecast rise
aggress deploy assumpt nearli
cumul well wrap benefit lower tax rate
pt creep admittedli touch elev
multipl accur captur bs option
view price-to-earnings bought easili via
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
bp mm advanc bioprocess
mm sold channel remain
gatan guid yet includ
less sell day sell day
 lsd msd eu volatil
industrial/appli slower due tough
eu lsd msd
tariff hw off-set give omx
ap divestitur hw close
china strong across product
biopharma servic pthn grew track
deliv mm yr synergi
gatan guid close
bs capac give war chest seen time
bn estim
pthn growth acceler st loui capac expans
increment
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
laboratori corp america
articl articl
time dissemin januari
analyst luke sergott ross muken primarili respons prepar research report attest follow view
opinion render research report reflect person view subject compani issuer part
research analyst compens directli relat specif recommend view research report
